The NT-proBNP level was also used in a recently published model for a two-year prediction of a primary composite endpoint (cardiovascular death or hospitalisation for heart failure) (AUC 0.71), cardiovascular death (AUC 0.71), and all-cause death (0.70) [5]. This evidence concerns the gene NPPB and heart failure.